Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 41, 2017 - Issue 3
378
Views
34
CrossRef citations to date
0
Altmetric
Original Article

Prevalence, Incidence, Trend, and Complications of Thalassemia in Iraq

, &
Pages 164-168 | Received 18 Apr 2017, Accepted 03 Jul 2017, Published online: 24 Aug 2017

References

  • Greer JP, Arber DA, Glader B, et al. Thalassemias and related disorders: quantitative disorders of hemoglobin synthesis. In: Borgna-Pignatti C, Galanello C, Editors. Wintrobe’s Clinical Hematology, 13th Ed. Philadelphia, PA, USA: Lippincott Williams & Wilkins. 2014:862–912.
  • Muncie HL Jr, Campbell J. α And β thalassemia. Am Fam Physician. 2009;80(4):339–344.
  • Thalassemia International Federation: guidelines for the clinical management of thalassemia, 2nd ed. 2008. Available from: http://www.thalassemia.org.cy
  • Weatherall DJ, Clegg JB. The Thalassaemia Syndromes, 4th ed. Oxford, Oxfordshire, UK: Blackwell Science Ltd., 2001.
  • Flint J, Harding RM, Boyce AJ, Clegg JB. The population genetics of the hemoglobinopathies. Bailliére’s Clin Haematol. 1998;11(1):1–50.
  • Vichinsky EP. Changing patterns of thalassemia worldwide. Ann NY Acad Sci. 2005;1054:18–24.
  • Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6)480–487.
  • Skarmoutsou C, Papassotiriou I, Traeger-Synodinos J, et al. Erythroid bone marrow activity and red cell hemoglobinization in iron-sufficient β-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin content. Correlation with genotypes and Hb A2 levels. Haematologica. 2003;88(6):631–636.
  • Cheung YF, Chow PC, Chan GC, Ha SY. Carotid intima-media thickness is increased and related to arterial stiffening in patients with β-thalassaemia major. Br J Haematol. 2006;135(5):732–734.
  • Cappellini M, Cohen A, Eleftheriou A, et al. Guidelines for the clinical management of thalassemia, 2nd revised edition. Nicosia, Cyprus: Thalassemia International Federation, 2008.
  • Iraqi Federal Board of Supreme Audit – Performance Evaluation Reports. [cited 2016 Aug 21]. Available from: http://www.d-raqaba-m.iq/pages_ar/repo_performance_ar.aspx.
  • Report of a Joint WHO-TIF Meeting on the Management of Hemoglobin Disorders held at Nicosia, Cyprus, [cited 2007 Nov 16-18]. Available from: http://apps.who.int/iris/handle/10665/43969
  • Modell B, Khan M, Darlison M. Survival in β-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet. 2000;355(9220):2051–2052.
  • Angastiniotis M, Vives Corrons JL, Soteriades ES, Eleftheriou A. The impact of migration on the health services for rare diseases in Europe: the example of haemoglobin disorders. ScientificWorldJournal. 2013;2013:727905.
  • Modell B, Darlison M, Birgens H, et al. Epidemiology of haemoglobin disorders in Europe: an overview. Scand J Clin Lab Invest. 2007;67(1):39–69.
  • Samavat A, Modell B. Iranian national thalassaemia screening programme. BMJ. 2004;329(7475):1134–1137.
  • Republic of Iraq: Iraq Family Health Survey 2006/7. World Health Organization, Regional Office for Eastern Mediterranean, [cited 2017 Jan 11]. Available from: http://www.emro.who.int/iraq/pdf/ifhs_report_en.pdf.
  • Alkindi S, Al Zadjali S, Al Madhani A, et al. Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates. Hemoglobin. 2010;34(2):135–144.
  • Mahmoud RA, El-Mazary AA, Khodeary A. Seroprevalence of hepatitis C, hepatitis B, cytomegalovirus, and human immunodeficiency viruses in multitransfused thalassemic children in Upper Egypt. Adv Hematol. 2016;2016:9032627.
  • Khorasani G, Kosaryan M, Vahidshahi K, et al. Results of the national program for prevention of β-thalassemia major in the Iranian governorate of Mazandaran. Hemoglobin. 2008;32(3):263–271.
  • Cao A, Galanello R. 2002. Effect of consanguinity on screening for thalassemia. N Engl J Med. 2002;347(15):1200–1202.
  • Lawson SE, Roberts IA, Amrolia P, et al. Bone marrow transplantation for β-thalassemia major: the UK experience in two paediatric centres. Br J Haematol. 2003;120(2):289–295.
  • Al-Sheyyab M, Batieha A, El-Khateeb M. The prevalence of hepatitis B, hepatitis C and human immune deficiency virus markers in multi-transfused patients. J Trop Pediatr. 2001;47(4):239–242.
  • Rahman M, Lodhi Y. Prospects and future of conservative management of β thalassemia major in a developing country. Pak J Med Scie. 2004;20(2):105–112.
  • Al-Naamani K, Al-Zakwani I, Al-Sinani S, et al. Prevalence of hepatitis C among multi-transfused thalassaemic patients in Oman. Sultan Qaboos Univ Med J. 2015;15(1):e46–e51.
  • Irshad M, Peter S. Spectrum of viral hepatitis in thalassemic children receiving multiple blood transfusions. Indian J Gastroenterol. 2002;21(5):183–184.
  • Al-Allawi NA, Jalal SD, Mohammad AM, et al. β-Thalassemia intermedia in Northern Iraq: a single center experience. Biomed Res Int. 2014;2014:262853. doi: 10.1155/2014/262853.
  • Tareef FR, Salwa SAW, Hadeer NA. Prevalence of hepatitis C among patients with Β thalassemia in Diyala, Iraq. Iraqi Acad Sci J. 2011;24(4):113–120.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.